Mankin H J, Trahan C A, Barnett N A, Laughead J, Bove C M, Pastores G M
The Massachusetts General Hospital, Boston, MA 02114, USA.
Clin Genet. 2006 Mar;69(3):209-17. doi: 10.1111/j.1399-0004.2006.00573.x.
Gaucher disease is an uncommon autosomal recessive disorder characterized by lysosomal storage of glucosyl ceramide, a material released during cell degradation. Patients with Gaucher disease often have significant hematologic, bone structural, and visceral problems which sometimes greatly affect their health and life style. Based on some extraordinary scientific discoveries over the past 45 years, a treatment system has evolved which consists of administration of an enzyme, which destroys the lysosome-stored material and to some extent restores the patients to good health. There are still some problems for these patients; however, and the purpose of the study is to define some of the clinical, sociologic, and psychologic problems with a specially designed questionnaire. Questionnaire data was collected for 128 patients from two institutions with complete anonymity, and the information compared against data from a National Health Interview Survey. The results show that many of the patients still have fairly extensive problems, which could possibly be helped by some alterations in treatment protocols.
戈谢病是一种罕见的常染色体隐性疾病,其特征是溶酶体中储存葡萄糖神经酰胺,这种物质在细胞降解过程中释放。戈谢病患者常常有严重的血液学、骨骼结构和内脏问题,有时会极大地影响他们的健康和生活方式。基于过去45年的一些非凡科学发现,已经形成了一种治疗体系,该体系包括给予一种酶,这种酶可破坏储存在溶酶体中的物质,并在一定程度上使患者恢复健康。然而,这些患者仍然存在一些问题,本研究的目的是通过一份专门设计的问卷来确定一些临床、社会学和心理学问题。从两个机构收集了128名患者的问卷数据,且完全匿名,并将这些信息与全国健康访谈调查的数据进行比较。结果表明,许多患者仍然存在相当广泛的问题,治疗方案的一些调整可能会对这些问题有所帮助。